BJRIのニュース
BJ''s Restaurant Stock Earns Upgrade. Profit Surged 150%. 2023/06/05 22:44:00 Investor''s Business Daily
A Relative Strength Rating upgrade for BJ''s Restaurants stock shows improving technical performance.
BJ''s Restaurants, Inc. to Present at the Oppenheimer 23rd Annual Consumer Growth and E-Commerce Conference Virtual Event 2023/05/30 17:14:00 Benzinga
HUNTINGTON BEACH, Calif., May 30, 2023 (GLOBE NEWSWIRE) -- BJ''s Restaurants, Inc. (NASDAQ: BJRI ) announced today that management will be participating virtually in a fireside chat at the Oppenheimer 23 rd Annual Consumer Growth and E-Commerce Conference on Tuesday, June 13, 2023, at approximately 1:30 p.m. (Eastern). BJ''s Management will also virtually meet with institutional investors. A live webcast of the presentation will be available on the "Investors" page of the Company''s website located at https://in v estors.bjsrestaurants.com . A replay will … Full story available on Benzinga.com
BJ''s Restaurants: Decent Rebound Growth Story, But Overvalued 2023/05/03 15:48:35 Seeking Alpha
BJ''s Restaurants hit all-time high revenue in 2022, but profitability hasn''t returned to pre-pandemic levels. Click here to see our take on BJRI stock.
BJ''s Restaurants (BJRI) Q1 2023 Earnings Call Transcript 2023/04/28 19:32:56 The Motley Fool
BJRI earnings call for the period ending March 31, 2023.
Mastercard To Rally Over 18%? Here Are 10 Other Analyst Forecasts For Friday 2023/04/28 12:40:40 Benzinga
Wells Fargo raised the price target for Molina Healthcare, Inc. (NYSE: MOH ) from $282 to $290. Wells Fargo analyst Stephen Baxter maintained an Underweight rating. Molina Healthcare shares gained 7.8% to close at $296.92 on Thursday. Credit Suisse boosted the price target for Eli Lilly and Company (NYSE: LLY ) from $400 to $420. Credit Suisse analyst Trung Huynh maintained an Outperform rating. Eli Lilly shares rose 0.9% to $394.00 in pre-market trading. Chardan Capital cut the price target for Seres Therapeutics, Inc. (NASDAQ: MCRB ) from $12 to $10. Chardan Capital analyst Keay Nakae maintained a Buy rating. Seres Therapeutics shares rose 1.5% to $5.40 in pre-market trading. Wedbush boosted BJ''s Restaurants, Inc. (NASDAQ: BJRI ) … Full story available on Benzinga.com
BJ''s Restaurants (BJRI) Q4 2022 Earnings Call Transcript 2023/02/17 05:00:26 The Motley Fool
BJRI earnings call for the period ending December 31, 2022.
BJ''s Restaurants, Inc. (BJRI) Q4 2022 Earnings Call Transcript 2023/02/17 02:52:07 Seeking Alpha
BJ’s Restaurants, Inc. (NASDAQ:NASDAQ:BJRI) Q4 2022 Results Conference Call February 16, 2023 5:00 PM ETCompany ParticipantsRana Schirmer - Director of Securities Greg Levin - President and…
BJ''s Restaurants Non-GAAP EPS of $0.07 beats by $0.01, revenue of $344.15M beats by $0.46M 2023/02/16 21:05:52 Seeking Alpha
BJ''s Restaurants press release (BJRI): Q4 Non-GAAP EPS of $0.07 beats by $0.01.Revenue of $344.15M (+18.1% Y/Y) beats by $0.46M.Total revenues increased 18.2% to $344.2 million…
BJ’s Restaurants, Inc. Reports Fiscal Fourth Quarter and Fiscal 2022 Results 2023/02/16 21:03:00 GlobeNewswire
HUNTINGTON BEACH, Calif., Feb. 16, 2023 (GLOBE NEWSWIRE) -- BJ’s Restaurants, Inc. (NASDAQ: BJRI) today reported financial results for its fiscal 2022 fourth quarter and year ended Tuesday, January 3, 2023.
BJ''s Restaurants, Inc. Reports Fiscal Fourth Quarter and Fiscal 2022 Results 2023/02/16 21:03:00 Benzinga
HUNTINGTON BEACH, Calif., Feb. 16, 2023 (GLOBE NEWSWIRE) -- BJ''s Restaurants, Inc. (NASDAQ: BJRI ) today reported financial results for its fiscal 2022 fourth quarter and year ended Tuesday, January 3, 2023. Fiscal Fourth Quarter 2022 Compared to Fourth Quarter 2021 Total revenues increased 18.2% to $344.2 million (14 weeks vs. 13 weeks). The extra operating week in fiscal 2022 contributed $26.5 million in sales. Excluding the extra operating week, fourth quarter revenues increased 9.0% compared to the same quarter in the prior year. Comparable restaurant sales increased 6.6% (14 weeks vs. 14 weeks) Total restaurant operating weeks increased 9.1% (14 weeks vs. 13 weeks) Net income of $4.0 million, compared to net loss of $4.7 million; diluted net income per share of $0.17, compared to diluted net loss per share of $0.20 (14 weeks vs. 13 weeks) Adjusted EBITDA of $26.1 million, compared to $13.7 million, as described below in the reconciliation between GAAP and non-GAAP adjusted financial measures (14 weeks vs. 13 weeks) Fourth quarter 2022 includes gift card breakage revenue of $3.2 million, or a diluted net benefit of $0.10 per share, as a result of the Company''s re-evaluation of its estimated redemption pattern resulting from the COVID-19 pandemic.
BJ''s Restaurants Q3 Earnings: A Great Quarter Is Still Not Enough (NASDAQ:BJRI) 2022/10/21 19:52:42 Seeking Alpha
BJ''s Restaurants reported robust financial results for its Q3 recently. Read more to see if BJRI is an attractive purchase for shareholders or not.
BJ''s Solid Q3 Results & Q4-To-Date Trends Relative To Expectations 2022/10/21 18:53:13 Benzinga
Wedbush analyst Nick Setyan reiterated a Neutral rating on the shares of BJ’s Restaurants Inc (NASDAQ: BJRI ) and raised the price target to $29 from $25. The analyst believes BJ’s may have one of the tougher paths towards an eventual top- and bottom-line normalization within the casual dining peer set as the post-COVID new normal unfolds. He added that the current discounts to its own pre-COVID multiples and casual … Full story available on Benzinga.com
BJs Restaurants (BJRI) Q3 2022 Earnings Call Transcript 2022/10/21 08:30:22 The Motley Fool
BJRI earnings call for the period ending September 30, 2022.